Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2000

View Archived Issues

Cell Therapeutics reviews third quarter developments

SangStat strengthens therapeutic focus

HGS and Dow to develop radiolabeled BLyS

Tanox discusses proprietary pipeline at investor conference

Select seeks approval in Canada to begin clinical trials of VeroPulse

AAPS news: pharmacokinetics and metabolism of HI-113 in mice

SB discusses research efforts in the area of 5-HT2C antagonists at AAPS meeting

Pharmacological characterization of novel antiasthmatic agent NIP-520

Karo Bio and Merck & Co. extend ER receptor drug discovery collaboration

Immunomodulatory peptide useful for producing Th1 switch in allergy

P2Y2 receptor agonists show promise for treatment of vaginal dryness

Allergan's novel glaucoma drug nears clinical trials

EMD-221829, a new PDE5 inhibitor: correlation of pharmacokinetics and pharmacodynamics

New Biotransport formulation of etoposide more effective than currently used formulation

PK interactions with doxorubicin and toxicity of MDR modulator LY-335979 reported at AAPS

Enhanced bioavailability of water-insoluble MTP inhibitor achieved with new formulation

Pharmacia files NDA for injectable parecoxib sodium

Clinical improvement seen in patients with undifferentiated spondyloarthropathy treated with subreum

Lanicemine now claimed for treatment of headache

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Potent, broad-spectrum erythromycin derivatives prepared at Abbott

Cathepsin inhibitors synthesized at AxyS claimed for osteoporosis, etc.

New amide inhibitors of cytokine and interleukin production from AstraZeneca

Lilly discovers novel polypeptide with potential in obesity Rx

Recently issued patent covers Pfizer's newest sorbitol dehydrogenase inhibitors

Xoma initiates phase I trial with ING-1 monoclonal antibody

ASRM 2000: hormonal effects, safety and pharmacokinetics of abarelix depot-F in endometriosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...